Category Archives: Best Performing Analysts
Adverum Biotechnologies (ADVM) Received its Third Buy in a Row
After SunTrust Robinson and Piper Sandler gave Adverum Biotechnologies (NASDAQ: ADVM) a Buy rating last month, the company received another Buy, this time from Chardan Capital. Analyst Gbola Amusa reiterated a Buy rating on Adverum Biotechnologies today. The company’s shares
Analysts Offer Insights on Healthcare Companies: TG Therapeutics (NASDAQ: TGTX) and Allogene Therapeutics (NASDAQ: ALLO)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TG Therapeutics (TGTX – Research Report) and Allogene Therapeutics (ALLO – Research Report) with bullish sentiments. TG Therapeutics (TGTX) H.C. Wainwright analyst
Northland Securities Maintains Their Buy Rating on Veeco (VECO)
Northland Securities analyst Gus Richard maintained a Buy rating on Veeco (VECO – Research Report) today and set a price target of $20.00. The company’s shares closed last Thursday at $11.37. According to TipRanks.com, Richard is a top 100 analyst
Salesforce (CRM) Receives a Hold from Needham
In a report released today, Scott Berg from Needham assigned a Hold rating to Salesforce (CRM – Research Report). The company’s shares closed last Thursday at $181.10. According to TipRanks.com, Berg is a top 100 analyst with an average return
Oppenheimer Believes Williams-Sonoma (NYSE: WSM) Won’t Stop Here
In a report released today, Brian Nagel from Oppenheimer maintained a Buy rating on Williams-Sonoma (WSM – Research Report). The company’s shares closed last Thursday at $73.03, close to its 52-week high of $77.00. According to TipRanks.com, Nagel is a
VMware (VMW) Receives a New Rating from a Top Analyst
Oppenheimer analyst Ittai Kidron assigned a Buy rating to VMware (VMW – Research Report) yesterday and set a price target of $175.00. The company’s shares closed last Thursday at $142.44. According to TipRanks.com, Kidron is a top 25 analyst with
